Demographics | Â |
---|---|
Female (n, %) | 149 (79.7) |
Age (mean, SD) | 54.9 (10.8) |
Caucasian (n, %) | 137 (73.3) |
Clinical assessment | Â |
Prior use of biologics (n, %) | 38 (20.3) |
VAS pain intensity (mean, SD) | 53.6 (20.8) |
SDAI (mean, SD) | 40.3 (11.9) |
Patient global assessment disease activity (mean, SD) | 61.6 (19.1) |
Physician global assessment disease activity (mean, SD) | 61.9 (14.9) |
Swollen joint count (mean, SD) | 11.4 (4.8) |
Tender joint count (mean, SD) | 14.7 (6.2) |
HRQoL scales | Â |
SF-36 Physical functioning (mean, SD) | 40.5 (21.7) |
SF-36 Role physical (mean, SD) | 42.8 (24.3) |
SF-36 Bodily pain (mean, SD) | 36.1 (16.9) |
SF-36 General health (mean, SD) | 40.4 (16.6) |
SF-36 Vitality (mean, SD) | 39.0 (19.7) |
SF-36 Social functioning (mean, SD) | 57.2 (26.1) |
SF-36 Role emotional (mean, SD) | 54.1 (26.7) |
SF-36 Mental health (mean, SD) | 56.8 (19.4) |
SF-36 Physical summary (mean, SD) | 33.8 (7.5) |
SF-36 Mental summary (mean, SD) | 40.5 (11.0) |
HAQ-DI (mean, SD) | 1.49 (0.6) |
FACIT-Fatigue (mean, SD) | 28.3 (10.1) |